Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo CAR-T therapy: from molecular design to precision delivery

Journal of Nanobiotechnology(2026)10.1186/s12951-026-04232-5Source: DataRank Database

In vivo CAR-T therapy: from molecular design to precision delivery is a research paper published in Journal of Nanobiotechnology (2026). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 8.64)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (4)

Wenjing Wen,Xuan Zhao ORCID,Gaofeng Liang ORCID,Huixian Li ORCID

Live enrichment

PubMed:41928252 PMC:PMC13169547 OpenAlex:https://openalex.org/W7148594679

National Key Research and Development Program of China

Grant: 2022YFE132800

Key R&D project of Henan Province

Grant: 221111310600

Joint Fund of Henan Province Science and Technology R&D Program

Grant: 225200810020

FWCI

8.64

Citation Percentile

1.0%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1186/s12951-026-04232-5

publisherhttps://doi.org/10.1186/s12951-026-04232-5

publisherhttps://link.springer.com/article/10.1186/s12951-026-04232-5

publisherhttps://link.springer.com/content/pdf/10.1186/s12951-026-04232-5.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41928252

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchCRISPR and Genetic EngineeringHumansImmunotherapy, AdoptiveReceptors, Chimeric AntigenAnimalsNeoplasmsGene Transfer TechniquesT-Lymphocytes

MeSH Terms

Receptors, Chimeric AntigenAnimalsHumansNeoplasmsReceptors, Antigen, T-CellRNA, MessengerT-LymphocytesImmunotherapy, AdoptiveGene Transfer Techniques

Keywords

In vivoEx vivoChimeric antigen receptorFood and drug administrationDrug deliveryDownregulation and upregulationEffectorWorkflowConstructionImmunotherapyGene deliveryIn Vivo Car-t